The Development of Biocatalysis as a Tool for Drug Discovery
DOI:
https://doi.org/10.2533/chimia.2020.368PMID:
32482213Keywords:
Biocatalysis, Chiral building blocks, Drug metabolites, Natural product modifications, Pharmacological activityAbstract
Enzymes are versatile biocatalysts capable of performing selective reactions. The advantages of enzymes in comparison to classical chemistry including chemical catalysts are the generally milder process conditions and avoidance of harmful reactants. Their high selectivity and specificity are especially beneficial for the enzymatic synthesis of new products with potential applications in drug research. Therefore, in the past decades, the utilization of isolated enzymes or whole-cell biocatalysts has spread through a growing number of biotechnological industries. The applications comprise the production of chiral building blocks for the pharmaceutical and fine chemical industry, the enzymatic synthesis of drug metabolites for testing of toxicity, function, biological activity, degradation and the production of biocatalytically modified natural products, which all play a role in drug discovery. Especially Oreste Ghisalba's contributions, which paved the way for the industrial use of enzymes, will be considered in this review.Downloads
Published
2020-05-27
Issue
Section
Scientific Articles
License
Copyright (c) 2020 Jenny Schwarz, Katrin Rosenthal, Radka Snajdrova, Matthias Kittelmann, Stephan Lütz
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
[1]
J. Schwarz, K. Rosenthal, R. Snajdrova, M. Kittelmann, S. Lütz, Chimia 2020, 74, 368, DOI: 10.2533/chimia.2020.368.